New antibiotic agents in the pipeline and how they can help overcome microbial resistance
出版年份 2013 全文链接
标题
New antibiotic agents in the pipeline and how they can help overcome microbial resistance
作者
关键词
-
出版物
Virulence
Volume 4, Issue 2, Pages 185-191
出版商
Informa UK Limited
发表日期
2013-02-07
DOI
10.4161/viru.22507
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Antimicrobial stewardship: A collaborative partnership between infection preventionists and health care epidemiologists
- (2012) Julia Moody et al. AMERICAN JOURNAL OF INFECTION CONTROL
- In VitroActivity and Microbiological Efficacy of Tedizolid (TR-700) against Gram-Positive Clinical Isolates from a Phase 2 Study of Oral Tedizolid Phosphate (TR-701) in Patients with Complicated Skin and Skin Structure Infections
- (2012) Philippe Prokocimer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cethromycin versus Clarithromycin for Community-Acquired Pneumonia: Comparative Efficacy and Safety Outcomes from Two Double-Blinded, Randomized, Parallel-Group, Multicenter, Multinational Noninferiority Studies
- (2012) Marci L. English et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bactericidal Activity of ACH-702 against Nondividing and Biofilm Staphylococci
- (2012) Steven D. Podos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activity of the Investigational Pleuromutilin Compound BC-3781 Tested against Gram-Positive Organisms Commonly Associated with Acute Bacterial Skin and Skin Structure Infections
- (2012) Helio S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States
- (2012) Ha T. Nguyen et al. ANTIVIRAL RESEARCH
- A Paradigm Shift in Drug Development for Treatment of Rare Multidrug-Resistant Gram-Negative Pathogens
- (2012) D. Alemayehu et al. CLINICAL INFECTIOUS DISEASES
- Oritavancin: Mechanism of Action
- (2012) George G. Zhanel et al. CLINICAL INFECTIOUS DISEASES
- Ceftaroline Fosamil: A Cephalosporin With Activity Against Methicillin-Resistant Staphylococcus Aureus
- (2012) Henry Poon et al. CLINICAL THERAPEUTICS
- Improving known classes of antibiotics: an optimistic approach for the future
- (2012) Karen Bush CURRENT OPINION IN PHARMACOLOGY
- Efflux Pumps of Gram-Negative Bacteria, a New Target for New Molecules
- (2012) Jean-Marie Pages et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Tuberculosis: The drug development pipeline at a glance
- (2012) Baptiste Villemagne et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
- (2012) George G Zhanel et al. Expert Review of Anti-Infective Therapy
- Policy Statement on Antimicrobial Stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS)
- (2012) Neil Fishman et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Characterization of -lactamase and porin mutants of Enterobacteriaceae selected with ceftaroline + avibactam (NXL104)
- (2012) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization
- (2012) J. M. Remy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin
- (2012) T. Imtiaz et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Outbreak of pulmonary infection caused by Klebsiella pneumoniae isolates harbouring blaIMP-4 and blaDHA-1 in a neonatal intensive care unit in China
- (2012) F. Yu et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Europe to boost development of new antimicrobial drugs
- (2012) Tony Kirby LANCET
- Antibiotic Resistance Is Prevalent in an Isolated Cave Microbiome
- (2012) Kirandeep Bhullar et al. PLoS One
- MDR, XDR, TDR tuberculosis: ominous progression
- (2012) Zarir F Udwadia THORAX
- Antibiotics in development targeting protein synthesis
- (2011) Joyce A. Sutcliffe Annals of the New York Academy of Sciences
- Are pleuromutilin antibiotics finally fit for human use?
- (2011) Rodger Novak Annals of the New York Academy of Sciences
- Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects
- (2011) Robert T. Cass et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro and In Vivo Profiles of ACH-702, an Isothiazoloquinolone, against Bacterial Pathogens
- (2011) Michael J. Pucci et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New antimicrobial agents on the horizon
- (2011) Karen Bush et al. BIOCHEMICAL PHARMACOLOGY
- Totally Drug-Resistant Tuberculosis in India
- (2011) Z. F. Udwadia et al. CLINICAL INFECTIOUS DISEASES
- Combating Antimicrobial Resistance: Policy Recommendations to Save Lives
- (2011) CLINICAL INFECTIOUS DISEASES
- Antibiotic stewardship
- (2011) Abhijit M. Bal et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Proposals Seek to Reduce Resistance, Boost Development of New Antibiotics
- (2011) Bridget M. Kuehn JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci
- (2011) I. Rodriguez-Avial et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study
- (2011) Timothy R Walsh et al. LANCET INFECTIOUS DISEASES
- Antimicrobial Stewardship
- (2011) Shira Doron et al. MAYO CLINIC PROCEEDINGS
- Current Concepts in Antimicrobial Therapy Against Resistant Gram-Negative Organisms: Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae, Carbapenem-Resistant Enterobacteriaceae, and Multidrug-Resistant Pseudomonas aeruginosa
- (2011) Souha S. Kanj et al. MAYO CLINIC PROCEEDINGS
- Antibiotic heterogeneity: from concept to practice
- (2010) A. M. Bal et al. Annals of the New York Academy of Sciences
- Cellular Pharmacokinetics of the Novel Biaryloxazolidinone Radezolid in Phagocytic Cells: Studies with Macrophages and Polymorphonuclear Neutrophils
- (2010) S. Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and Safety of Nemonoxacin versus Levofloxacin for Community-Acquired Pneumonia
- (2010) D. J. J. van Rensburg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cellular Pharmacodynamics of the Novel Biaryloxazolidinone Radezolid: Studies with Infected Phagocytic and Nonphagocytic cells, Using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila
- (2010) S. Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Antituberculosis Activities of ACH-702, a Novel Isothiazoloquinolone, against Quinolone-Susceptible and Quinolone-Resistant Isolates
- (2010) M. J. Pucci et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contrasting Effects of Acidic pH on the Extracellular and Intracellular Activities of the Anti-Gram-Positive Fluoroquinolones Moxifloxacin and Delafloxacin againstStaphylococcus aureus
- (2010) Sandrine Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Resistance to Linezolid Is Mediated by thecfrGene in the First Report of an Outbreak of Linezolid‐ResistantStaphylococcus aureus
- (2010) Gracia Morales et al. CLINICAL INFECTIOUS DISEASES
- Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens
- (2010) E. Rubinstein et al. CLINICAL INFECTIOUS DISEASES
- Combating evolution with intelligent design: the neoglycoside ACHN-490
- (2010) Eliana S Armstrong et al. CURRENT OPINION IN MICROBIOLOGY
- Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City
- (2010) D. Landman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection
- (2010) Elizabeth B. Hirsch et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of chequerboard combinations of ceftaroline and NXL104 versus -lactamase-producing Enterobacteriaceae
- (2010) S. Mushtaq et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters
- (2010) S. Mushtaq et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009)
- (2010) David J. Farrell et al. JOURNAL OF INFECTION
- Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan
- (2009) Abhijeet S. Nadkarni et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Probing the Differential Interactions of Quinazolinedione PD 0305970 and Quinolones with Gyrase and Topoisomerase IV
- (2009) X.-S. Pan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model
- (2008) K. N. Williams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains
- (2008) K. J. Shaw et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
- (2007) B. Spellberg et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started